ALLO vs K · rev $22.0K vs P/E 23, $29.03B cap
Allogene Therapeutics Inc (ALLO) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
K does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the ALLO and K stock pages for the full models.
Not investment advice.